Business and Finance

Specific, technology-based anticounterfeiting measures are a tactical response to a strategic problem. Holistic prevention strategies are needed

At 28% pharmaceutical sales, chain pharmacy still represents the single largest channel for delivering prescriptions to patients

Coming off a record-setting year, ABC stresses growth in generics, and services revolving around specialty pharmaceuticals

Effective integration of a company’s contract strategy with operations can have a big impact on financial performance

While drug spending by clients averaged 3.3% last year, higher spending growth is predicted for the next three years

US market will enter negative growth this year, says IMS Health

Specialty manufacturers have a range of options to consider in how to go to market

Better use of available data can add rigor to analyzing managed-markets contracts, thereby allocating rebates / discounts more effectively

US total reaches $291.5 billion; dispensed prescriptions up 0.9%

New unit will ship from La Vergne, TN specialty-care products warehouse

Specialty GPO is doubling attendance year-over-year

US total reaches $291.5 billion; dispensed prescriptions up 0.9%

Although human trials in the U.S. are still a novelty, developers are identifying both sources and protocols for conducting therapy

Although beset by less-than-friendly federal reimbursement policies, independent pharmacies are maintaining their viability for pharmaceutical delivery

Higher complexity—and expense—are the reality for most drug research, says Tufts

Higher co-pays, ‘NDC block policies’ and multiple tiers add to drug benefit complexity

New Deloitte study finds “profound” positive and negative ROIs for combined therapies and diagnostics based on genetics